The in silico analysis of this study also suggested that PI3K/AKT pathway may be a key pathway in the mechanism of COP in bladder cancer treatment, which is consistent with the mechanism of COP in treating other human malignancies [15]. The gene discussed is AKT1; the disease is urinary bladder cancer.